Gastrointestinal symptoms in patients with liver cirrhosis: Associations with nutritional status and health-related quality of life

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 12, 2006, Pages 1464-1472

  Kalaitzakis, Evangelos ^a   Simrén, Magnus ^a   Olsson, Rolf ^a   Henfridsson, Pia ^a   Hugosson, Irene ^a   Bengtsson, Maria ^a   Björnsson, Einar ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gastrointestinal symptoms; Health related quality of life; Liver cirrhosis; Nutritional status; Weight loss

Indexed keywords

LACTULOSE;

ABDOMINAL PAIN; ADULT; ANTHROPOMETRY; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CONSTIPATION; DIARRHEA; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL QUALITY OF LIFE INDEX; GASTROINTESTINAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; INDIGESTION; LIVER CIRRHOSIS; LIVER WEIGHT; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SHORT FORM 36; VALIDATION STUDY; WEIGHT CHANGE; WEIGHT REDUCTION;

FEMALE; GASTROINTESTINAL DISEASES; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 33751117207     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600825117     Document Type: Article

References (51)

1. Campillo B, Bories PN, Pornin B, Devanlay M. Influence of liver failure, ascites, and energy expenditure on the response to oral nutrition in alcoholic liver cirrhosis. Nutrition 1997;13:613-21.
2. Selberg O, Böttcher J, Tusch G, Pichlmayr R, Henkel E, Muller MJ. Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 1997;25:652-7.
3. Roongpisuthipong C, Sobhonlidsuk A, Nantiruj K, Songchitsomboon S. Nutritional assessment in various stages of liver cirrhosis. Nutrition 2001;17:761-5.
4. Matos C, Porayko MK, Francisco-Ziller N, DiCecco S. Nutrition and chronic liver disease. J Clin Gastroenterol 2002;35:391-7.
5. Campillo B, Richardet JP, Scherman E, Bories PN. Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study. Nutrition 2003;19:515-21.
6. Galati JS, Monsour HP, Dyer CH, Seagren S, Quigley EMM. A survey of the frequency of gastrointestinal complaints in patients with chronic liver disease. Gastroenterology 1995;108:A1068.
7. Dumitrascu DL, Pascu O, Draghici A, Pop S, Dumitrascu D, Iacob G. Functional dyspepsia in liver cirrhosis. Rom J Intern Med 1996;34:91-6.
8. Björnsson E, Simrén M, Olsson R, Chapman RW. Fatigue in patients with sclerosing cholangitis. Scand J Gastroenterol 2004;39:961-8.
9. Björnsson E, Simrén M, Olsson R, Chapman RW. Fatigue is not a specific symptom in patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2005;17:351-7.
10. Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, et al. Factors associated with poor health-related quality of life in patients with cirrhosis. Gastroenterology 2001;120:170-8.
11. Kanwal F, Hays R, Kilbourne AM, Dulai GS, Gralnek IM. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease? Am J Gastroenterol 2004;99:1726-32.
12. Häuser W, Holtmann G, Grandt D. Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenterol Hepatol 2004;2:157-63.
13. Creed F, Ratcliffe J, Fermandez L, Tomenson B, Palmer S, Rigby C, et al. Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med 2001;134:860-8.
14. Simrén M, Abrahamsson H, Svedlund J, Björnsson ES. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol 2001;36:545-52.
15. Simrén M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Björnsson ES. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002;97:389-96.
16. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-70.
17. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy: definition, nomenclature, diagnosis, and quantification. Final report of the working party at the 11th World Congress of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-21.
18. Symreng T. Arm anthropometry in large reference population and in surgical patients. Clin Nutr 1982;1:211-9.
19. Stratton RJ, Green CJ, Elia M. Disease-related malnutrition: an evidence-based approach to treatment. Oxon: CAB International; 2003.
20. Svedlund J, Sjödin I, Dotevall G. GSRS-A clinical Rating Scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129-34.
21. Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 1993;28:681-7.
22. Svedlund J, Sullivan M, Liedman B, Lundell L. Long-term consequences of gastrectomy for patient's quality of life: the impact of reconstructive techniques. Am J Gastroenterol 1999;94:438-45.
23. Dimenäs E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol 1996;Suppl 221:8-13.
24. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
25. McHorney CA, Ware JE Jr, Rogers W, Raczek AE, Lu JF. The validity and relative precision of MOS short- and longform health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care 1992;30:MS253-65.
26. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
27. Sullivan M, Karlsson J, Taft C, Ware JE. SF-36 Health Survey: Swedish manual and interpretation guide, 2nd ed. Gothenburg: Sahlgrenska University Hospital; 2002.
28. Chesta J, Defilippi C, Defilippi C. Abnormalities in proximal small bowel motility in patients with cirrhosis. Hepatology 1993;17:828-32.
29. Gunnarsdottir SA, Sadik R, Shev S, Simrén M, Sjövall H, Stotzer PO, et al. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol 2003;98:1362-70.
30. Galati JS, Holdeman KP, Dalrymple GV, Harrison KA, Quigley EM. Delayed gastric emptying of both the liquid and solid components of a meal in chronic liver disease. Am J Gastroenterol 1994;89:708-11.
31. Sadik R, Abrahamsson H, Björnsson E, Gunnarsdottir A, Stotzer PO. Etiology of portal hypertension may influence gastrointestinal transit. Scand J Gastroenterol 2003;38:1039-44.
32. Madsen JL, Brinch K, Hansen EF, Fuglsang S. Gastrointestinal motor function in patients with portal hypertension. Scand J Gastroenterol 2000;35:490-3.
33. Dumitrascu DL, Barnert J, Wienbeck M. Gastric emptying in liver cirrhosis. The effect of the type of meal. Eur J Gastroenterol Hepatol 1997;9:1073-80.
34. Izbéki F, Kiss I, Wittmann T, Varkonyi TT, Legrady P, Lonovics J. Impaired accommodation of proximal stomach in patients with alcoholic liver cirrhosis. Scand J Gastroenterol 2002;37:1403-10.
35. Aqel BA, Scolapio JS, Dickson RC, Burton DD, Bouras EP. Contribution of ascites to impaired gastric function and nutritional intake in patients with cirrhosis and ascites. Clin Gastroenterol Hepatol 2005;3:1095-100.
36. Stanghellini V, Tosetti C, Paternico A, Barbara G, Morselli-Labate AM, Monetti N, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996;110:1036-42.
37. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distension in functional dyspepsia. Gastroenterology 2001;121:526-35.
38. Björnsson E, Sjöberg J, Ringström G, Norstrom M, Simrén M, Abrahamsson H. Effects of duodenal lipids on gastric sensitivity and relaxation in patients with ulcer-like and dysmotility-like dyspepsia. Digestion 2003;67:209-17.
39. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998;115:1346-52.
40. Conn HO. The theoretic therapy of hepatic encephalopathy. In: Conn HO, editor. Hepatic encephalopathy syndromes and therapies. Bloomington: Medi-Ed Press; 1994. pp 135-47.
41. Fritz E, Hammer HF, Lipp RW, Hogenauer C, Stauber R, Hammer J. Effects of lactulose and polyethylene glycol on colonic transit. Aliment Pharmacol Ther 2005;21:259-68.
42. Basilisco G, Marino B, Passerini L, Ogliari C. Abdominal distension after colonic lactulose fermentation recorded by a new extensometer. Neurogastroenterol Motil 2003;15:427-33.
43. Gassul MA, Cabré E. Nutrition in inflammatory bowel disease. Curr Opin Clin Nutr Metab 2001;4:561-9.
44. Kalaitzakis E, Tornblom H, Jerlstad P, Björnsson E, Simrén M. A caloric satiety drinking test in patients with liver cirrhosis: relationship with upper gastrointestinal symptoms. Gastroenterology 2005;128:W1726.
45. Andreyev HJN, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 1998;34:503-9.
46. Petruson KM, Silander EM, Hammerlid EB. Quality of life as predictor of weight loss in patients with head and neck cancer. Head Neck 2005;27:302-10.
47. Brantervik ÅM, Jacobsson IE, Grimby A, Wallen TC, Bosaeus IG. Older hospitalised patients at risk of malnutrition: correlation with quality of life, aid from the social welfare system and length of stay. Age Ageing 2005;34:444-9.
48. Konturek SJ, Gonciarz M, Gonciarz Z, Bielanski W, Mazur W, Mularczyk A, et al. Progastrin and its products from patients with chronic viral hepatitis and liver cirrhosis. Scand J Gastroenterol 2003;38:643-7.
49. Wu CS, Lin CY, Liaw YF. Helicobacter pylori in cirrhotic patients with peptic ulcer disease: a prospective, case controlled study. Gastrointest Endosc 1995;42:424-7.
50. Chen LS, Lin HC, Hwang SJ, Lee FY, Hou MC, Lee SD. Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension. J Gastroenterol Hepatol 1996;11:59-64.
51. Siringo S, Burroughs AK, Bolondi L, Muia A, DiFebo G, Miglioli M, et al. Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol 1995;22:633-41.